These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1363953)

  • 1. Quality assurance of immunophenotyping.
    Bradley J
    Asian Pac J Allergy Immunol; 1992 Dec; 10(2):85-7. PubMed ID: 1363953
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection.
    MMWR Recomm Rep; 1992 May; 41(RR-8):1-17. PubMed ID: 1350319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Jan; 46(RR-2):1-29. PubMed ID: 9011774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
    Calvelli T; Denny TN; Paxton H; Gelman R; Kagan J
    Cytometry; 1993 Oct; 14(7):702-15. PubMed ID: 8243200
    [No Abstract]   [Full Text] [Related]  

  • 5. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1994 Mar; 43(RR-3):1-21. PubMed ID: 7908403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved precision in the enumeration of absolute numbers of lymphocyte phenotypes with long-term monthly proficiency testing.
    Rickman WJ; Monical C; Waxdal MJ
    Ann N Y Acad Sci; 1993 Mar; 677():53-8. PubMed ID: 8494246
    [No Abstract]   [Full Text] [Related]  

  • 7. From the Centers for Disease Control. Availability of flow cytometric immunophenotyping of lymphocytes to hospital patients--United States.
    JAMA; 1992 Sep; 268(11):1395-6. PubMed ID: 1355118
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.
    Schenker EL; Hultin LE; Bauer KD; Ferbas J; Margolick JB; Giorgi JV
    Cytometry; 1993; 14(3):307-17. PubMed ID: 8472607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of flow cytometric immunophenotyping of lymphocytes to hospital patients--United States, 1990.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Aug; 41(33):608-10. PubMed ID: 1354327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of 4- and 6-color flow cytometers and acquisition/analysis softwares on the determination of lymphocyte subsets in HIV infection.
    Ashman M; Sachdeva N; Davila L; Scott G; Mitchell C; Cintron L; Rathore M; Asthana D
    Cytometry B Clin Cytom; 2007 Sep; 72(5):380-6. PubMed ID: 17226862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control and quality assurance in flow cytometry.
    Mayall BH
    Ann N Y Acad Sci; 1993 Mar; 677():78-81. PubMed ID: 8494248
    [No Abstract]   [Full Text] [Related]  

  • 12. A decision-support system for flow cytometry immunophenotyping.
    Asare AL; Ellis JS; Caldwell CW
    Am J Clin Pathol; 2002 Oct; 118(4):567-73. PubMed ID: 12375644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of leukocyte immunophenotyping as influenced by the HIV/AIDS pandemic: a short history of the development of gating strategies for CD4+ T-cell enumeration.
    Mandy FF; Bergeron M; Minkus T
    Cytometry; 1997 Aug; 30(4):157-65. PubMed ID: 9298833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Department of Army lymphocyte immunophenotyping quality assurance program.
    Rickman WJ; Waxdal MJ; Monical C; Damato JD; Burke DS
    Clin Immunol Immunopathol; 1989 Jul; 52(1):85-95. PubMed ID: 2721036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National external quality assessment scheme for lymphocyte immunophenotyping in Belgium.
    Van Blerk M; Bernier M; Bossuyt X; Chatelain B; D'Hautcourt JL; Demanet C; Kestens L; Van Bockstaele D; Crucitti T; Libeer JC
    Clin Chem Lab Med; 2003 Mar; 41(3):323-30. PubMed ID: 12705342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influencing factors of single-platform method of flow cytometry in the detection of immunophenotype of peripheral blood lymphocytes in HIV/AIDS patients].
    Zhang FJ; Yao J; Zhao HX; Feng X; Lu LH; Han N; Liu ZY; Lin H
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):124-6. PubMed ID: 15774223
    [No Abstract]   [Full Text] [Related]  

  • 17. Setting up and calibration of a flow cytometer for multicolor immunophenotyping.
    Kraan J; Gratama JW; Keeney M; D'Hautcourt JL
    J Biol Regul Homeost Agents; 2003; 17(3):223-33. PubMed ID: 14524607
    [No Abstract]   [Full Text] [Related]  

  • 18. The new AIDS case definition. Implications for San Francisco.
    Chang SW; Kate MH; Hernandez SR
    JAMA; 1992 Feb; 267(7):973-5. PubMed ID: 1346406
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
    Nicholson JK
    Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Caribbean: riding the dark horse of HIV/AIDS towards a brighter future.
    Landis RC
    Cytometry B Clin Cytom; 2007 Mar; 72(2):153-5. PubMed ID: 17285624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.